1.
Sex differences in the association between diabetes and cancer: a systematic review and meta-analysis of 121 cohorts including 20 million individuals and one million events
by Ohkuma, Toshiaki
Diabetologia, 2018-07-20, Vol.61 (10), p.2140-2154

2.
Safety and efficacy of dalcetrapib on atherosclerotic disease using novel non-invasive multimodality imaging (dal-PLAQUE): a randomised clinical trial
by Fayad, Zahi A, Prof
The Lancet (British edition), 2011, Vol.378 (9802), p.1547-1559

3.
Diabetes as a risk factor for heart failure in women and men: a systematic review and meta-analysis of 47 cohorts including 12 million individuals
by Ohkuma, Toshiaki
Diabetologia, 2019-07-18, Vol.62 (9), p.1550-1560

4.
Diabetes as risk factor for incident coronary heart disease in women compared with men: a systematic review and meta-analysis of 64 cohorts including 858,507 individuals and 28,203...
by Peters, Sanne A. E
Diabetologia, 2014-05-25, Vol.57 (8), p.1542-1551

5.
Impact of age, age at diagnosis and duration of diabetes on the risk of macrovascular and microvascular complications and death in type 2 diabetes
by Zoungas, Sophia
Diabetologia, 2014-09-17, Vol.57 (12), p.2465-2474

6.
Circulating amino acids and the risk of macrovascular, microvascular and mortality outcomes in individuals with type 2 diabetes: results from the ADVANCE trial
by Welsh, Paul
Diabetologia, 2018-05-04, Vol.61 (7), p.1581-1591

7.
The relationship between eGFR slope and subsequent risk of vascular outcomes and all-cause mortality in type 2 diabetes: the ADVANCE-ON study
by Oshima, Megumi
Diabetologia, 2019-07-13, Vol.62 (11), p.1988-1997

8.
The molecular biology of pelvi-ureteric junction obstruction
by Jackson, Laura
Pediatric nephrology (Berlin, West), 2017-03-13, Vol.33 (4), p.553-571

9.

10.
Is there evidence for sex differences in the association between diabetes and cancer? Reply to Dankner R, Boker LK, Freedman LS [letter]
by Ohkuma, Toshiaki
Diabetologia, 2018-11-03, Vol.62 (1), p.201-201

11.
Estimation of individual beneficial and adverse effects of intensive glucose control for patients with type 2 diabetes
by van der Leeuw, Joep
Diabetologia, 2016-12, Vol.59 (12), p.2603–2612-2612

12.
Parenthood and the risk of diabetes in men and women: a 7 year prospective study of 0.5 million individuals
by Peters, Sanne A. E
Diabetologia, 2016-05-18, Vol.59 (8), p.1675-1682

13.
Predictors of change in carotid atherosclerotic plaque inflammation and burden as measured by 18-FDG-PET and MRI, respectively, in the dal-PLAQUE study
by Mani, Venkatesh
The International Journal of Cardiovascular Imaging, 2014-03, Vol.30 (3), p.571-582

14.
An Economic Evaluation of a Perindopril-Based Blood Pressure Lowering Regimen for Patients Who Have Suffered a Cerebrovascular Event
by Tavakoli, Manouchehr
The European journal of health economics, 2009-02-01, Vol.10 (1), p.111-119

15.
Predicting the effects of blood pressure-lowering treatment on major cardiovascular events for individual patients with type 2 diabetes mellitus results from action in diabetes and...
by Van Der Leeuw, Joep
Hypertension (Dallas, Tex. 1979), 2015-01-01, Vol.65 (1), p.115-121

16.
A 10-Year Experience with Mastectomy and Tissue Expander Placement to Facilitate Subsequent Radiation and Reconstruction
by Ayoub, Zeina
Annals of surgical oncology, 2017-08-01, Vol.24 (10), p.2965-2971

17.
Symptom changes in five dimensions of the Positive and Negative Syndrome Scale in refractory psychosis
by Woodward, T.S
European archives of psychiatry and clinical neuroscience, 2014, Vol.264 (8), p.673-682

18.
The 21-gene recurrence score complements IBTR! Estimates in early-stage, hormone receptor-positive, HER2-normal, lymph node-negative breast cancer
by Thaker, Nikhil G
SpringerPlus, 2015-01-30, Vol.4 (1), p.36-36
